Bloomberg News

Warner Chilcott Gets U.S. Attorney Subpoena on Drug Practice

February 24, 2012

(Updates with details on request in second paragraph.)

Feb. 24 (Bloomberg) -- Warner Chilcott Plc and some non- executive employees received a subpoena from the U.S. Attorney’s Office in Massachusetts for information on a “wide range of matters,” including its sales and marketing practices.

The Feb. 22 subpoena seeks information on payments to people who are in a position to recommend drugs, medical education, clinical trials, off-label use and employee training for key products, the Dublin-based company said today in a filing with the U.S. Securities and Exchange Commission.

“We intend to cooperate in responding to the subpoena but cannot predict or determine the impact of this inquiry on our future financial condition or results of operations,” Warner Chilcott said.

--Editors: Stephen Farr, Andrew Dunn

To contact the reporter on this story: Sophia Pearson in Philadelphia at

To contact the editor responsible for this story: Michael Hytha at

Steve Ballmer, Power Forward
blog comments powered by Disqus